I-CREI HOMING ENDONUCLEASE VARIANTS HAVING NOVEL CLEAVAGE SPECIFICITY AND USE THEREOF
    1.
    发明申请
    I-CREI HOMING ENDONUCLEASE VARIANTS HAVING NOVEL CLEAVAGE SPECIFICITY AND USE THEREOF 审中-公开
    I-CREI HOMING ENDONUCLEASE VARIANTS具有新颖的清除特性及其使用

    公开(公告)号:US20130209437A1

    公开(公告)日:2013-08-15

    申请号:US13744068

    申请日:2013-01-17

    Applicant: Cellectis

    Inventor: Frederic Paques

    CPC classification number: C12N9/22 A01N63/00 C12N15/1086 C12N15/902

    Abstract: A method for engineering I-CreI homing endonuclease variants able to cleave mutant I-CreI sites having variation in positions ±8 to ±10. A I-CreI homing endonuclease variant obtainable by said method, a vector encoding said variant, a cell, an animal or a plant modified by said vector. Use of said I-CreI endonuclease variant and derived products for genetic engineering, genome therapy and antiviral therapy.

    Abstract translation: 用于工程化I-CreI归巢内切核酸酶变体的方法,其能够切割具有±8至±10位置变异的突变I-CreI位点。 通过所述方法可获得的I-CreI归巢内切核酸酶变体,编码所述变体的载体,细胞,动物或由所述载体修饰的植物。 使用所述I-CreI内切核酸酶变体和衍生产物用于基因工程,基因组治疗和抗病毒治疗。

Patent Agency Ranking